HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Data Supplement Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Kindich, R. Articles by Wullich, B. Search for Related Content PubMed PubMed Citation Articles by Kindich, R. Articles by Wullich, B. Related Collections Molecular Diagnostics and Genetics

Application of a Modified Real-Time PCR Technique for Relative Gene Copy Number Quantification to the Determination of the Relationship between NKX3.1 Loss and MYC Gain in Prostate Cancer

¹ Clinic of Urology and Pediatric Urology, University of the Saarland, Homburg/Saar, Germany; Departments of² Urology and ³ Pathology, Heinrich-Heine University, Düsseldorf, Germany

^aaddress correspondence to this author at: Clinic of Urology and Pediatric Urology, University of the Saarland, 66421 Homburg/Saar, Germany; fax 49-6841-1624795, e-mail urbwul@uniklinik-saarland.de)

The first 300 words of the full text of this article appear below.

Gene amplifications and deletions play an important role in the pathogenesis of solid tumors, including prostate cancer. Real-time PCR is a powerful tool for quantitative DNA analysis, particularly when starting quantities of tumor tissue are minimal (1)(2)(3)(4)(5). In the present study, we describe a modification of the 2^–CT method, which recently was shown to be suitable for relative gene expression analyses (6). We used our technique to analyze prostate cancer cell lines and tissue samples to determine the relationship between homeodomain-containing transcription factor 3.1 (NKX3.1) and MYC gene copy number alterations in this tumor type.

The specimens analyzed included (a) blood samples from healthy donors; (b) the prostate cancer cell lines DU145 (ATCC no. HTB-81) and PC3 (ATCC no. CRL-1435) and their derived sublines DU145MN1, PC3-N, and PC3-125-1L (7); (c) the colorectal cell line COLO320DM (ATCC no. CCL-220), which harbors a high-level MYC amplification; and (d) primary prostate adenocarcinoma samples obtained after radical prostatectomy from previously untreated patients. The specimens were histologically verified, and samples were taken as described previously (8). We extracted DNA from the snap-frozen prostate carcinoma samples, blood samples, and cell lines, using the Blood and Cell Culture DNA Midi Kit (Qiagen).

We performed quantitative real-time PCR using the LightCycler^TM system (Roche Diagnostics) with the FastStart DNA Master SYBR Green I LightCycler Kit (Roche Diagnostics). PCRs were run in duplicate with 20-µL reaction volumes containing 1x SYBR Green I PCR Buffer Mix, 5 mM MgCl₂, 0.5 µM each primer, 1x FastStart Taq DNA Polymerase (Roche Diagnostics), and 50 ng of genomic DNA. The cycling conditions are given in Table 1 . The hot start PCR method was applied to prevent incomplete DNA denaturation as discussed by Wilhelm et . . . [Full Text of this Article]

The following articles in journals at HighWire Press have cited this article:

				C. O'Brien, G. Cavet, A. Pandita, X. Hu, L. Haydu, S. Mohan, K. Toy, C. S. Rivers, Z. Modrusan, L. C. Amler, et al. Functional Genomics Identifies ABCC3 as a Mediator of Taxane Resistance in HER2-Amplified Breast Cancer Cancer Res., July 1, 2008; 68(13): 5380 - 5389. [Abstract] [Full Text] [PDF]

				V. Jung, R. Kindich, J. Kamradt, M. Jung, M. Muller, W. A. Schulz, R. Engers, G. Unteregger, M. Stockle, R. Zimmermann, et al. Genomic and Expression Analysis of the 3q25-q26 Amplification Unit Reveals TLOC1/SEC62 as a Probable Target Gene in Prostate Cancer Mol. Cancer Res., March 1, 2006; 4(3): 169 - 176. [Abstract] [Full Text] [PDF]